Heavy Periods: When to See a Doctor and What Your Bleeding Is Telling You

What Counts as a "Heavy" Period?

Most women have no reliable way to measure blood loss at home, but the clinical threshold is straightforward. ACOG defines heavy menstrual bleeding as blood loss exceeding 80 mL per cycle, lasting more than 7 days, or frequent enough to interfere with your daily life. In practical terms, that translates to changing a fully soaked pad or tampon every hour for two or more consecutive hours, passing clots larger than a quarter, or bleeding through onto clothing or bedding.

The Pictorial Blood Assessment Chart

Because measuring milliliters at home is not realistic, many clinicians use the Pictorial Blood Assessment Chart (PBAC). Each lightly soaked pad scores 1 point, a fully soaked pad scores 5, and a clot the size of a small coin scores 1. A PBAC score above 100 per cycle correlates with blood loss exceeding 80 mL and is considered clinically significant.

What "Normal" Actually Looks Like

A typical period lasts 4 to 6 days and involves 30 to 40 mL of total blood loss. You should be able to use a pad or tampon for 3 to 4 hours comfortably. If you are doubling up products, setting alarms to change protection at night, or avoiding activities because of bleeding, your period is not normal by clinical standards, regardless of how long you have experienced it.

When to See a Doctor Right Away

Some symptoms mean you should not wait for a routine appointment.

Go to an emergency room or call your provider the same day if you are soaking through a pad or tampon every 30 minutes for more than 2 hours, passing clots larger than a golf ball, feeling faint or lightheaded from blood loss, or if you have any possibility of pregnancy. Ectopic pregnancy is life-threatening and can present with heavy vaginal bleeding; it requires immediate evaluation.

Signs That Warrant a Non-Emergency Appointment Within Two Weeks

Book a clinic visit soon if you notice any of the following:

• Periods have changed significantly in flow or duration in the past 3 to 6 months
• You are passing clots regularly, even if smaller than a quarter
• Bleeding lasts more than 7 days consistently
• You feel persistently tired, short of breath with minor exertion, or your nails are brittle (possible anemia symptoms)
• You have postmenopausal bleeding, meaning any bleeding more than 12 months after your final period

Postmenopausal bleeding requires evaluation to rule out endometrial cancer, and the same-day urgency applies if bleeding is heavy.

What Causes Heavy Periods?

The causes differ meaningfully depending on your life stage, and this is one area where a generic symptom list fails women. Your clinician will likely use the FIGO PALM-COEIN classification system, which sorts causes into structural problems (PALM) and non-structural problems (COEIN).

Structural Causes (PALM)

Polyps. Endometrial or cervical polyps are benign overgrowths of tissue that can cause irregular or heavy bleeding. They are more common after age 40. Endometrial polyps are found in roughly 10% of women evaluated for abnormal uterine bleeding.

Adenomyosis. When the uterine lining grows into the muscle wall, the result is often heavy, painful periods and an enlarged uterus. It most often affects women in their 30s and 40s, particularly those who have had children.

Leiomyomas (fibroids). Fibroids are the most common structural cause of heavy bleeding in reproductive-age women. They are present in up to 70% of white women and up to 80% of Black women by age 50, and Black women are diagnosed earlier and experience more severe symptoms on average. Submucosal fibroids, those nearest the uterine cavity, cause the heaviest bleeding.

Malignancy and hyperplasia. Endometrial cancer and its precursor, endometrial hyperplasia, must be ruled out in any woman over 45 with new-onset heavy bleeding, or in younger women with prolonged unopposed estrogen exposure (as in PCOS or obesity).

Non-Structural Causes (COEIN)

Coagulopathy. Bleeding disorders are underdiagnosed in women. Von Willebrand disease affects approximately 1% of the general population but accounts for up to 20% of women evaluated for heavy menstrual bleeding. If you have had heavy periods since your very first menstrual cycle, easy bruising, or prolonged bleeding after dental work or surgery, ask specifically about bleeding disorder testing.

Ovulatory dysfunction. Irregular or absent ovulation leads to progesterone deficiency and unopposed estrogen, which causes the uterine lining to build up and then shed heavily and unpredictably. This is the dominant mechanism in PCOS and in perimenopause.

Endometrial causes. Sometimes the lining itself produces too much of a local clot-dissolving enzyme (plasminogen activator), leading to heavier flow even when the uterus looks structurally normal on imaging.

Iatrogenic causes. Copper IUDs increase menstrual blood loss by an average of 20 to 50% in the first year. Anticoagulants such as warfarin, rivaroxaban, and apixaban also cause heavier periods, as can some antipsychotics that raise prolactin and disrupt ovulation.

Not yet classified. This catch-all includes conditions that do not fit neatly into other categories.

How Life Stage Changes the Cause and the Conversation

Adolescence (Ages 11 to 19)

Heavy bleeding from the very first period is the hallmark of an underlying bleeding disorder. Von Willebrand disease should be considered in all adolescents presenting with heavy menstrual bleeding at menarche, according to ACOG. Anovulatory cycles are also common in the first 2 to 3 years after the first period because the hypothalamic-pituitary-ovarian axis is still maturing, and this produces irregular, sometimes heavy bleeding without structural disease.

Reproductive Years (Ages 20 to 40)

Fibroids, endometriosis-related adenomyosis, PCOS-driven anovulation, and thyroid dysfunction are the most common culprits. Hypothyroidism in particular can dramatically worsen menstrual bleeding. TSH levels above 10 mIU/L are associated with significantly heavier periods, and treating the thyroid often resolves the bleeding without any uterine-directed therapy.

If you are trying to conceive, the cause of heavy bleeding matters enormously for your fertility plan. Submucosal fibroids and endometrial polyps reduce implantation rates, while PCOS-related anovulation means you may not be ovulating at all.

Perimenopause (Typically Ages 45 to 55, Sometimes Earlier)

Perimenopause is one of the most common times for heavy bleeding to appear or worsen, and women are routinely told this is "just hormones" without adequate investigation. Anovulatory cycles become more frequent as ovarian reserve declines, progesterone drops, and estrogen fluctuates. The result can be cycles that are wildly variable in timing and very heavy when they do arrive.

A practical framework for perimenopausal heavy bleeding: any woman over 45 with a change in bleeding pattern needs an endometrial biopsy to rule out hyperplasia or malignancy before hormonal management is started. This is not optional. After hyperplasia is excluded, treatment choices include the levonorgestrel IUD (which reduces bleeding by up to 86% in clinical trials), oral progestins, combined hormonal contraception, or tranexamic acid. Menopausal hormone therapy does not treat heavy bleeding and may worsen it if not balanced with adequate progestogen.

Postmenopause (More Than 12 Months After Final Period)

Any vaginal bleeding after menopause is abnormal and requires evaluation, period. Endometrial cancer accounts for approximately 10% of postmenopausal bleeding episodes. Transvaginal ultrasound measuring endometrial thickness is the standard first step; an endometrial biopsy follows if the stripe is 4 mm or thicker.

How Heavy Periods Are Diagnosed

Your provider will combine your history, a physical exam, and targeted tests. Expect questions about cycle length, flow volume (products used per day), clot size, and how long this has been occurring. Bring a menstrual diary or period-tracking app data if you have it.

Laboratory Tests

Standard blood work includes:

• Complete blood count (CBC) to check for anemia; hemoglobin below 12 g/dL in women indicates anemia
• Ferritin, the most sensitive marker of iron stores (often depleted before hemoglobin drops)
• TSH to screen for thyroid disease
• Pregnancy test in any woman of reproductive age
• Coagulation studies (PT, aPTT, von Willebrand factor antigen and activity) if a bleeding disorder is suspected

Imaging

Transvaginal ultrasound is the first-line imaging study and can detect fibroids, polyps, and adenomyosis. Sonohysterography (saline infusion sonography) adds more detail for intracavitary lesions. MRI is reserved for complex cases, particularly when fibroids are numerous or adenomyosis needs to be characterized before surgery.

Endometrial Biopsy

ACOG recommends endometrial biopsy in women over 45 with abnormal uterine bleeding and in younger women with risk factors for endometrial hyperplasia, including obesity (BMI <35 kg/m²), PCOS, or a history of tamoxifen use. The procedure takes about 2 to 3 minutes in the office and causes cramping similar to a strong period pain.

Treatment for Heavy Periods: What Works and for Whom

Treatment depends entirely on cause, desire for future pregnancy, and your personal preferences about hormones and procedures.

Hormonal Options

Levonorgestrel IUD (Mirena, Liletta). This is the most effective non-surgical treatment available. The ECLIPSE trial found the levonorgestrel IUD reduced menstrual blood loss by 86% at 12 months compared to 24% with standard medical therapy. It works locally in the uterus, systemic hormone absorption is minimal, and it is appropriate across reproductive years and into perimenopause. It is also one of the most effective contraceptives available, which matters for perimenopausal women who still need contraception.

Combined oral contraceptive pills. COCs thin the endometrial lining and typically reduce flow by 30 to 50%. They are particularly useful when you also want contraception or when heavy bleeding accompanies hormonal acne or cycle irregularity from PCOS.

Oral progestins. Norethindrone acetate 5 mg taken daily from cycle days 5 to 26 can reduce blood loss by around 80% in anovulatory bleeding. This is a reasonable option if hormonal contraception is not needed and the IUD is declined.

GnRH agonists (leuprolide). Used short-term (3 to 6 months) before surgery or to manage fibroids, leuprolide creates a temporary medically induced menopause. It reduces fibroid volume by 35 to 65% on average but causes significant bone density loss with prolonged use. Add-back therapy with low-dose estrogen and progestogen is recommended if treatment exceeds 3 months.

Elagolix (Oriahnn). An oral GnRH antagonist FDA-approved for heavy menstrual bleeding due to uterine fibroids. In the ELARIS UF-I trial, elagolix with hormonal add-back reduced heavy menstrual bleeding in 68.5% of treated women compared to 8.7% on placebo. Treatment is limited to 24 months due to bone density considerations.

Non-Hormonal Options

Tranexamic acid. This antifibrinolytic drug reduces clot breakdown in the uterine lining. Taken as 1.3 g orally three times daily for up to 5 days during your period, it reduces blood loss by approximately 40% compared to placebo. The FDA approved tranexamic acid (Lysteda) specifically for heavy menstrual bleeding in 2009. It does not affect ovulation, making it appropriate for women who are trying to conceive.

NSAIDs. Ibuprofen 600 mg or naproxen sodium taken with the first sign of bleeding and continued for the first 3 days reduces prostaglandin-driven blood loss by roughly 25 to 35%. Less effective than tranexamic acid but useful when both pain and heavy flow need treatment.

Procedural Options

Endometrial ablation. A same-day procedure that destroys the uterine lining. Appropriate only if your family is complete. Approximately 80% of women report significantly lighter periods after ablation, and 15 to 35% achieve amenorrhea. Not appropriate in the presence of suspected endometrial cancer or significant fibroids that distort the cavity.

Uterine fibroid embolization (UFE). A radiological procedure that cuts off blood supply to fibroids. Preserves the uterus and reduces fibroid volume substantially. Pregnancy after UFE is possible but carries higher obstetric risk; this option is generally not recommended if you plan to conceive.

Myomectomy. Surgical removal of fibroids while preserving the uterus. The preferred surgical option when fertility is desired. Black women with fibroids are more likely to need myomectomy at a younger age and face higher surgical complication rates in some studies, a disparity driven partly by delayed diagnosis and larger fibroid burden at presentation.

Hysterectomy. The only definitive cure for heavy bleeding. Appropriate when other treatments have failed, family is complete, and the burden of bleeding is significant. Not a first-line option and never the only option presented to a woman.

Iron Deficiency and Anemia: The Hidden Harm of Untreated Heavy Periods

Heavy menstrual bleeding is the leading cause of iron deficiency in premenopausal women worldwide. Up to 30% of women with heavy menstrual bleeding develop iron-deficiency anemia. Depleted iron affects concentration, mood, exercise tolerance, hair growth, and immune function, often years before hemoglobin drops enough to appear on a standard CBC.

Ask your provider to check ferritin specifically. A ferritin below 30 ng/mL indicates depleted stores even when hemoglobin is technically normal. Oral iron supplementation (ferrous sulfate 325 mg every other day is as effective as daily dosing with fewer GI side effects, per data from the IRONOUT trial) is first-line. Women with severe anemia, very low ferritin, or intolerance to oral iron may need intravenous iron infusion before surgery or as primary treatment.

Who This Is Right for, and Who Needs a Different Path

Women Who May Do Well With Medical Management First

• Reproductive-age women with no identified structural cause, normal thyroid, and negative pregnancy test
• Perimenopausal women with benign endometrial biopsy who want to avoid surgery
• Adolescents with anovulatory bleeding not caused by a bleeding disorder
• Women with fibroids who are 1 to 2 years from natural menopause (fibroids regress after estrogen declines)

Women Who Need Expedited Specialist Referral

• Any woman with postmenopausal bleeding
• Women with a fibroid burden too large for medical management (uterine size >12 weeks)
• Adolescents with suspected bleeding disorders (referral to hematology alongside gynecology)
• Women in whom endometrial biopsy shows hyperplasia with atypia or malignancy
• Women who have failed two or more medical treatments

Pregnancy-Specific Considerations

If you are pregnant or might be pregnant, heavy vaginal bleeding requires immediate evaluation. In the first trimester, the main concerns are miscarriage and ectopic pregnancy. Ectopic pregnancy occurs in approximately 2% of all pregnancies and is the leading cause of maternal mortality in the first trimester. Tranexamic acid is category B in older FDA terminology, but its use in pregnancy is limited to specific clinical settings and requires physician direction. Hormonal contraceptives are, by definition, stopped when pregnancy is desired; the levonorgestrel IUD must be removed before conception. NSAIDs are avoided after 20 weeks of pregnancy due to oligohydramnios risk.

Women who have recently delivered should be aware that heavy lochia (postpartum bleeding lasting more than 6 weeks or soaking more than one pad per hour) warrants evaluation for retained placental tissue, postpartum hemorrhage complications, or postpartum thyroiditis, which can disrupt cycles after it resolves.

A Note on Evidence Gaps for Women

Women have been historically excluded or under-represented in cardiovascular and hematology trials that inform bleeding management guidelines. Most fibroid treatment data comes from trials that, until recently, did not stratify by race despite significant disparities in fibroid burden and outcomes between Black and white women. The COMPARE-UF registry is actively working to correct this. A 2021 analysis from COMPARE-UF found Black women presented with significantly larger fibroids and more severe anemia at enrollment than white women, confirming that current standard-of-care thresholds may underserve this population. If you feel your symptoms are being minimized, asking for a specialist referral is appropriate and reasonable.